DrugPatentWatch Database Preview
Array Biopharma Inc Company Profile
What is the competitive landscape for ARRAY BIOPHARMA INC, and when can generic versions of ARRAY BIOPHARMA INC drugs launch?
ARRAY BIOPHARMA INC has two approved drugs.
There are eighteen US patents protecting ARRAY BIOPHARMA INC drugs.
There are two hundred and eleven patent family members on ARRAY BIOPHARMA INC drugs in fifty-one countries.
Summary for Array Biopharma Inc
| International Patents: | 211 |
| US Patents: | 18 |
| Tradenames: | 2 |
| Ingredients: | 2 |
| NDAs: | 2 |
Drugs and US Patents for Array Biopharma Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Array Biopharma Inc | BRAFTOVI | encorafenib | CAPSULE;ORAL | 210496-002 | Jun 27, 2018 | RX | Yes | Yes | 9,850,229 | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Array Biopharma Inc | MEKTOVI | binimetinib | TABLET;ORAL | 210498-001 | Jun 27, 2018 | RX | Yes | Yes | 9,850,229 | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Array Biopharma Inc | BRAFTOVI | encorafenib | CAPSULE;ORAL | 210496-001 | Jun 27, 2018 | RX | Yes | No | 9,593,100 | ➤ Try a Free Trial | Y | ➤ Try a Free Trial | |||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
International Patents for Array Biopharma Inc Drugs
| Country | Document Number | Estimated Expiration |
|---|---|---|
| Eurasian Patent Organization | 025222 | ➤ Try a Free Trial |
| Israel | 204419 | ➤ Try a Free Trial |
| Japan | 6216325 | ➤ Try a Free Trial |
| Country | Document Number | Estimated Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
